CA967978A - Preparation of a hypocholesterolemic - Google Patents

Preparation of a hypocholesterolemic

Info

Publication number
CA967978A
CA967978A CA125,793A CA125793A CA967978A CA 967978 A CA967978 A CA 967978A CA 125793 A CA125793 A CA 125793A CA 967978 A CA967978 A CA 967978A
Authority
CA
Canada
Prior art keywords
hypocholesterolemic
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA125,793A
Other languages
English (en)
Other versions
CA125793S (en
Inventor
George G. Hazen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA967978A publication Critical patent/CA967978A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/76—Acyl halides containing halogen outside the carbonyl halide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA125,793A 1970-10-30 1971-10-21 Preparation of a hypocholesterolemic Expired CA967978A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8573170A 1970-10-30 1970-10-30

Publications (1)

Publication Number Publication Date
CA967978A true CA967978A (en) 1975-05-20

Family

ID=22193571

Family Applications (1)

Application Number Title Priority Date Filing Date
CA125,793A Expired CA967978A (en) 1970-10-30 1971-10-21 Preparation of a hypocholesterolemic

Country Status (7)

Country Link
CA (1) CA967978A (enExample)
CH (1) CH566296A5 (enExample)
DK (1) DK133742B (enExample)
ES (1) ES396275A1 (enExample)
HU (1) HU165827B (enExample)
NL (1) NL7112509A (enExample)
PL (1) PL87251B1 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US6624194B1 (en) 1999-06-04 2003-09-23 Metabolex, Inc. Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
WO2007020381A2 (en) 2005-08-15 2007-02-22 Syngenta Participations Ag Process for the synthesis of mandipropamid and derivatives thereof
US7199259B2 (en) 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
US7576131B2 (en) 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US7714131B2 (en) 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US6613802B1 (en) 1999-06-04 2003-09-02 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6624194B1 (en) 1999-06-04 2003-09-23 Metabolex, Inc. Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6646004B1 (en) 1999-06-04 2003-11-11 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7576131B2 (en) 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US8329749B2 (en) 1999-06-04 2012-12-11 Metabolex, Inc. Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
US8354448B2 (en) 1999-06-04 2013-01-15 Metabolex, Inc. Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes
US8481597B2 (en) 1999-06-04 2013-07-09 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US7199259B2 (en) 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
WO2007020381A2 (en) 2005-08-15 2007-02-22 Syngenta Participations Ag Process for the synthesis of mandipropamid and derivatives thereof
US7714131B2 (en) 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof

Also Published As

Publication number Publication date
DK133742C (enExample) 1976-11-29
CH566296A5 (en) 1975-09-15
HU165827B (enExample) 1974-11-28
ES396275A1 (es) 1974-11-16
NL7112509A (enExample) 1972-05-03
DK133742B (da) 1976-07-12
PL87251B1 (enExample) 1976-06-30

Similar Documents

Publication Publication Date Title
AU3591371A (en) A improved form of brassiere
CA941386A (en) Ortho-methylation of a phenol
CA990053A (en) Wall forming assembly
AU460922B2 (en) A process for the preparation of bis-/p-chlorophenoxy/acetyl-urea
CA967978A (en) Preparation of a hypocholesterolemic
CA942308A (en) Preparation of 2-trifluoromethylquinoxaline-di-n-oxides
CA958392A (en) Projecteur a faisceau lumineux oblique
CA971345A (en) Method of forming a spacer-expander
AU455685B2 (en) A process for the preparation of 6-meethyl-19-nor-pregnenes
AU454902B2 (en) A connection
CA989418A (en) Preparation of phenylaminoethanols
CA920608A (en) Preparation of dihydroterephthalates
CA847852A (en) Preparation of a glycopeptide
CA933946A (en) Preparation of 4-mercaptophenols
CA839493A (en) Compteur chronometrique a prepaiement
CA845701A (en) Broyeurs a marteaux
AU443871B2 (en) A vibrator
AU436728B2 (en) A novel substituted 1-phenoxy-2-aminopropane
CA809237A (en) Preparation of a cycloalkylmethylaminobenzophenone
CA846680A (en) Meubles a elements
CA922643A (en) Sound-retarding wall elements
CA872769A (en) Preparation of a gelatinous compound
CA873873A (en) Preparation of adamantane-d16
AU450658B2 (en) Preparation of 4-aminophenols
CA842809A (en) Preparation of 2-amidobenzomorphans